» Articles » PMID: 2036994

Follistatin Binds to Both Activin and Inhibin Through the Common Subunit

Overview
Journal Endocrinology
Specialty Endocrinology
Date 1991 Jun 1
PMID 2036994
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Inhibin, activin, and follistatin are three families of polypeptides originally isolated and characterized from ovarian follicular fluid based on their modulation of FSH release from pituitary cell culture. In addition to their effects on FSH synthesis and secretion, inhibin and activin have other biological functions. By contrast, the physiological significance of follistatin was obscure, until it was discovered that follistatin is a binding protein to activin. Since activin binds to follistatin, it is imperative to determine the nature of the activin/follistatin binding complex. Moreover, because inhibin contains a beta-subunit derived from activin, it is important to determine whether inhibin will also bind follistatin. Using a double-ligand blotting technique, we have determined that activin-A has two binding sites for follistatin, whereas inhibin-A has only one binding site for follistatin. Therefore, these results suggest that follistatin binds to both activin and inhibin through the common beta-subunit.

Citing Articles

Unraveling the Dynamics of Estrogen and Progesterone Signaling in the Endometrium: An Overview.

Dias Da Silva I, Wuidar V, Zielonka M, Pequeux C Cells. 2024; 13(15.

PMID: 39120268 PMC: 11312103. DOI: 10.3390/cells13151236.


Follistatin Forms a Stable Complex With Inhibin A That Does Not Interfere With Activin A Antagonism.

Kappes E, Kattamuri C, Czepnik M, Yarawsky A, Brule E, Wang Y Endocrinology. 2023; 164(3).

PMID: 36718082 PMC: 10282738. DOI: 10.1210/endocr/bqad017.


Follistatin is a crucial chemoattractant for mouse decidualized endometrial stromal cell migration by JNK signalling.

Liu G, Qi Y, Wu J, Lin F, Liu Z, Cui X J Cell Mol Med. 2022; 27(1):127-140.

PMID: 36528873 PMC: 9806297. DOI: 10.1111/jcmm.17648.


INHBA is a mediator of aggressive tumor behavior in HER2+ basal breast cancer.

Liu M, Smith R, Liby T, Chiotti K, Lopez C, Korkola J Breast Cancer Res. 2022; 24(1):18.

PMID: 35248133 PMC: 8898494. DOI: 10.1186/s13058-022-01512-4.


Dual Roles of the Activin Signaling Pathway in Pancreatic Cancer.

Qiu W, Kuo C, Tian Y, Su G Biomedicines. 2021; 9(7).

PMID: 34356885 PMC: 8301451. DOI: 10.3390/biomedicines9070821.